{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:31:04Z","timestamp":1768876264937,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Leukotrienes are potent inflammatory mediators, which in a number of studies have been found to be associated with ischemic stroke pathology: gene variants affecting leukotriene synthesis, including the FLAP (ALOX5AP) gene, have in human studies shown correlation to stroke incidence, and animal studies have demonstrated protective properties of various leukotriene-disrupting drugs. However, no study has hitherto described a significant effect of a genetic manipulation of the leukotriene system on ischemic stroke. Therefore, we decided to compare the damage from focal cerebral ischemia between wild type and FLAP knockout mice. Damage was evaluated by infarct staining and a functional test after middle cerebral artery occlusion in 20 wild type and 20 knockout male mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mortality-adjusted median infarct size was 18.4 (3.2-76.7) mm<jats:sup>3<\/jats:sup>in the knockout group, compared to 72.0 (16.7-174.0) mm<jats:sup>3<\/jats:sup>in the wild type group (p\u2009&lt;\u20090.0005). There was also a tendency of improved functional score in the knockout group (p\u2009=\u20090.068). Analysis of bone marrow cells confirmed that knockout animals had lost their ability to form leukotrienes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Since the local inflammatory reaction after ischemic stroke is known to contribute to the brain tissue damage, the group difference seen in the current study could be a consequence of a milder inflammatory reaction in the knockout group. Our results add evidence to the notion that leukotrienes are important in ischemic stroke, and that blocked leukotriene production ameliorates cerebral damage.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2202-13-146","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T05:14:58Z","timestamp":1354252498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis"],"prefix":"10.1186","volume":"13","author":[{"given":"Jakob O","family":"Str\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Strid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,30]]},"reference":[{"issue":"5","key":"2839_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G: Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010, 87 (5): 779-789. 10.1189\/jlb.1109766.","journal-title":"J Leukoc Biol"},{"key":"2839_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0083-6729(08)61134-6","volume":"39","author":"B Samuelsson","year":"1982","unstructured":"Samuelsson B, Hammarstr\u00f6m S: Leukotrienes: a novel group of biologically active compounds. Vitam Horm. 1982, 39: 1-30.","journal-title":"Vitam Horm"},{"issue":"5","key":"2839_CR3","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1172\/JCI117889","volume":"95","author":"JW Woods","year":"1995","unstructured":"Woods JW, Coffey MJ, Brock TG, Singer II, Peters-Golden M: 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J Clin Invest. 1995, 95 (5): 2035-2046. 10.1172\/JCI117889.","journal-title":"J Clin Invest"},{"issue":"1","key":"2839_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/bbrc.1993.2227","volume":"196","author":"M Peters-Golden","year":"1993","unstructured":"Peters-Golden M, McNish RW: Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem Biophys Res Commun. 1993, 196 (1): 147-153. 10.1006\/bbrc.1993.2227.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2839_CR5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1084\/jem.178.6.1935","volume":"178","author":"JW Woods","year":"1993","unstructured":"Woods JW, Evans JF, Ethier D, Scott S, Vickers PJ, Hearn L, Heibein JA, Charleson S, Singer II: 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med. 1993, 178 (6): 1935-1946. 10.1084\/jem.178.6.1935.","journal-title":"J Exp Med"},{"issue":"1","key":"2839_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1432-1033.1996.0250q.x","volume":"238","author":"M Pouliot","year":"1996","unstructured":"Pouliot M, McDonald PP, Krump E, Mancini JA, McColl SR, Weech PK, Borgeat P: Colocalization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem \/ FEBS. 1996, 238 (1): 250-258. 10.1111\/j.1432-1033.1996.0250q.x.","journal-title":"Eur J Biochem \/ FEBS"},{"issue":"6255","key":"2839_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/343282a0","volume":"343","author":"RA Dixon","year":"1990","unstructured":"Dixon RA, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK: Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990, 343 (6255): 282-284. 10.1038\/343282a0.","journal-title":"Nature"},{"issue":"37","key":"2839_CR8","doi-asserted-by":"publisher","first-page":"21652","DOI":"10.1074\/jbc.270.37.21652","volume":"270","author":"TG Brock","year":"1995","unstructured":"Brock TG, McNish RW, Peters-Golden M: Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J Biol Chem. 1995, 270 (37): 21652-21658. 10.1074\/jbc.270.37.21652.","journal-title":"J Biol Chem"},{"issue":"17","key":"2839_CR9","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.lfs.2006.05.022","volume":"79","author":"Y Zhou","year":"2006","unstructured":"Zhou Y, Wei EQ, Fang SH, Chu LS, Wang ML, Zhang WP, Yu GL, Ye YL, Lin SC, Chen Z: Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sci. 2006, 79 (17): 1645-1656. 10.1016\/j.lfs.2006.05.022.","journal-title":"Life Sci"},{"key":"2839_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.05.066","volume":"189","author":"CZ Zhao","year":"2011","unstructured":"Zhao CZ, Zhao B, Zhang XY, Huang XQ, Shi WZ, Liu HL, Fang SH, Lu YB, Zhang WP, Tang FD, et al: Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats. Neuroscience. 2011, 189: 1-11.","journal-title":"Neuroscience"},{"issue":"1","key":"2839_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2006.10.065","volume":"412","author":"SH Fang","year":"2007","unstructured":"Fang SH, Zhou Y, Chu LS, Zhang WP, Wang ML, Yu GL, Peng F, Wei EQ: Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia. Neurosci Lett. 2007, 412 (1): 78-83. 10.1016\/j.neulet.2006.10.065.","journal-title":"Neurosci Lett"},{"issue":"12","key":"2839_CR12","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/j.1745-7254.2006.00458.x","volume":"27","author":"YJ Zhang","year":"2006","unstructured":"Zhang YJ, Zhang L, Ye YL, Fang SH, Zhou Y, Zhang WP, Lu YB, Wei EQ: Cysteinyl leukotriene receptors CysLT1 and CysLT2 are upregulated in acute neuronal injury after focal cerebral ischemia in mice. Acta Pharmacol Sin. 2006, 27 (12): 1553-1560. 10.1111\/j.1745-7254.2006.00458.x.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"2839_CR13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.neuroscience.2006.02.051","volume":"140","author":"SH Fang","year":"2006","unstructured":"Fang SH, Wei EQ, Zhou Y, Wang ML, Zhang WP, Yu GL, Chu LS, Chen Z: Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience. 2006, 140 (3): 969-979. 10.1016\/j.neuroscience.2006.02.051.","journal-title":"Neuroscience"},{"issue":"2","key":"2839_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/jcbfm.1987.43","volume":"7","author":"E Westerberg","year":"1987","unstructured":"Westerberg E, Deshpande JK, Wieloch T: Regional differences in arachidonic acid release in rat hippocampal CA1 and CA3 regions during cerebral ischemia. J Cerebral Blood Flow Metab. 1987, 7 (2): 189-192. 10.1038\/jcbfm.1987.43.","journal-title":"J Cerebral Blood Flow Metab"},{"issue":"3","key":"2839_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000330341","volume":"32","author":"R Ji","year":"2011","unstructured":"Ji R, Jia J, Ma X, Wu J, Zhang Y, Xu L: Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke. Cerebrovasc Dis. 2011, 32 (3): 261-268.","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"2839_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/STROKEAHA.107.491969","volume":"39","author":"S Bevan","year":"2008","unstructured":"Bevan S, Dichgans M, Wiechmann HE, Gschwendtner A, Meitinger T, Markus HS: Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations. Stroke. 2008, 39 (4): 1109-1114. 10.1161\/STROKEAHA.107.491969.","journal-title":"Stroke"},{"issue":"3","key":"2839_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ng1311","volume":"36","author":"A Helgadottir","year":"2004","unstructured":"Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004, 36 (3): 233-239. 10.1038\/ng1311.","journal-title":"Nat Genet"},{"issue":"8","key":"2839_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1538-7836.2010.03903.x","volume":"8","author":"JJ Freiberg","year":"2010","unstructured":"Freiberg JJ, Tybjaerg-Hansen A, Nordestgaard BG: Novel mutations in leukotriene C4 synthase and risk of cardiovascular disease based on genotypes from 50,000 individuals. J Thromb Haemost. 2010, 8 (8): 1694-1701. 10.1111\/j.1538-7836.2010.03903.x.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2839_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jaci.2011.11.052","volume":"129","author":"E Ingelsson","year":"2012","unstructured":"Ingelsson E, Yin L, Back M: Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease. J Allergy Clin Immunol. 2012, 129 (3): 702-707. 10.1016\/j.jaci.2011.11.052. e702","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2839_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1745-7254.2007.00578.x","volume":"28","author":"LS Chu","year":"2007","unstructured":"Chu LS, Fang SH, Zhou Y, Yu GL, Wang ML, Zhang WP, Wei EQ: Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats. Acta Pharmacol Sin. 2007, 28 (6): 763-772. 10.1111\/j.1745-7254.2007.00578.x.","journal-title":"Acta Pharmacol Sin"},{"key":"2839_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1742-2094-3-12","volume":"3","author":"M Jatana","year":"2006","unstructured":"Jatana M, Giri S, Ansari MA, Elango C, Singh AK, Singh I, Khan M: Inhibition of NF-\u03baB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J Neuroinflammation. 2006, 3: 12-10.1186\/1742-2094-3-12.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"2839_CR22","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1023\/A:1020916905312","volume":"24","author":"AM Rao","year":"1999","unstructured":"Rao AM, Hatcher JF, Kindy MS, Dempsey RJ: Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem Res. 1999, 24 (10): 1225-1232. 10.1023\/A:1020916905312.","journal-title":"Neurochem Res"},{"issue":"1","key":"2839_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000081072","volume":"73","author":"GL Yu","year":"2005","unstructured":"Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, Zhao MH: Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology. 2005, 73 (1): 31-40. 10.1159\/000081072.","journal-title":"Pharmacology"},{"issue":"4","key":"2839_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.2042-7158.2010.01238.x","volume":"63","author":"R Zhao","year":"2011","unstructured":"Zhao R, Shi WZ, Zhang YM, Fang SH, Wei EQ: Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. J Pharm Pharmacol. 2011, 63 (4): 550-557. 10.1111\/j.2042-7158.2010.01238.x.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"2839_CR25","first-page":"1","volume":"39","author":"SH Zhang","year":"2004","unstructured":"Zhang SH, Wei EQ, Zhu CY, Chen Z, Zhang SF: [Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats]. Yao Xue Xue Bao. 2004, 39 (1): 1-4.","journal-title":"Yao Xue Xue Bao"},{"issue":"10","key":"2839_CR26","first-page":"871","volume":"23","author":"WP Zhang","year":"2002","unstructured":"Zhang WP, Wei EQ, Mei RH, Zhu CY, Zhao MH: Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin. 2002, 23 (10): 871-877.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"2839_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1745-7254.2006.00290.x","volume":"27","author":"LS Chu","year":"2006","unstructured":"Chu LS, Wei EQ, Yu GL, Fang SH, Zhou Y, Wang ML, Zhang WP: Pranlukast reduces neutrophil but not macrophage\/microglial accumulation in brain after focal cerebral ischemia in mice. Acta Pharmacol Sin. 2006, 27 (3): 282-288. 10.1111\/j.1745-7254.2006.00290.x.","journal-title":"Acta Pharmacol Sin"},{"issue":"1\u20132","key":"2839_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2005.06.046","volume":"1053","author":"GL Yu","year":"2005","unstructured":"Yu GL, Wei EQ, Wang ML, Zhang WP, Zhang SH, Weng JQ, Chu LS, Fang SH, Zhou Y, Chen Z, et al: Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice. Brain Res. 2005, 1053 (1\u20132): 116-125.","journal-title":"Brain Res"},{"issue":"10","key":"2839_CR29","doi-asserted-by":"publisher","first-page":"e3579","DOI":"10.1371\/journal.pone.0003579","volume":"3","author":"D Lecca","year":"2008","unstructured":"Lecca D, Trincavelli ML, Gelosa P, Sironi L, Ciana P, Fumagalli M, Villa G, Verderio C, Grumelli C, Guerrini U, et al: The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One. 2008, 3 (10): e3579-10.1371\/journal.pone.0003579.","journal-title":"PLoS One"},{"key":"2839_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2011.11.066","volume":"202","author":"B Zhao","year":"2012","unstructured":"Zhao B, Zhao CZ, Zhang XY, Huang XQ, Shi WZ, Fang SH, Lu YB, Zhang WP, Xia Q, Wei EQ: The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats. Neuroscience. 2012, 202: 42-57.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"2839_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.brainres.2004.01.018","volume":"1004","author":"K Kitagawa","year":"2004","unstructured":"Kitagawa K, Matsumoto M, Hori M: Cerebral ischemia in 5-lipoxygenase knockout mice. Brain Res. 2004, 1004 (1\u20132): 198-202.","journal-title":"Brain Res"},{"issue":"1","key":"2839_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-5793(80)80407-8","volume":"122","author":"S Hammarstr\u00f6m","year":"1980","unstructured":"Hammarstr\u00f6m S, Samuelsson B: Detection of leukotriene A4 as an intermediate in the biosynthesis of leukotrienes C4 and D4. FEBS Lett. 1980, 122 (1): 83-86. 10.1016\/0014-5793(80)80407-8.","journal-title":"FEBS Lett"},{"issue":"9","key":"2839_CR33","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.76.9.4275","volume":"76","author":"RC Murphy","year":"1979","unstructured":"Murphy RC, Hammarstr\u00f6m S, Samuelsson B: Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979, 76 (9): 4275-4279. 10.1073\/pnas.76.9.4275.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2839_CR34","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/0006-291X(79)91203-8","volume":"91","author":"S Hammarstr\u00f6m","year":"1979","unstructured":"Hammarstr\u00f6m S, Murphy RC, Samuelsson B, Clark DA, Mioskowski C, Corey EJ: Structure of leukotriene C. Identification of the amino acid part. Biochem Biophys Res Commun. 1979, 91 (4): 1266-1272. 10.1016\/0006-291X(79)91203-8.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2839_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1073\/pnas.85.2.416","volume":"85","author":"RA Dixon","year":"1988","unstructured":"Dixon RA, Jones RE, Diehl RE, Bennett CD, Kargman S, Rouzer CA: Cloning of the cDNA for human 5-lipoxygenase. Proc Natl Acad Sci U S A. 1988, 85 (2): 416-420. 10.1073\/pnas.85.2.416.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2839_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1432-1033.1993.tb18012.x","volume":"215","author":"M Abramovitz","year":"1993","unstructured":"Abramovitz M, Wong E, Cox ME, Richardson CD, Li C, Vickers PJ: 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem \/ FEBS. 1993, 215 (1): 105-111. 10.1111\/j.1432-1033.1993.tb18012.x.","journal-title":"Eur J Biochem \/ FEBS"},{"issue":"6","key":"2839_CR37","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1084\/jem.185.6.1065","volume":"185","author":"RS Byrum","year":"1997","unstructured":"Byrum RS, Goulet JL, Griffiths RJ, Koller BH: Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J Exp Med. 1997, 185 (6): 1065-1075. 10.1084\/jem.185.6.1065.","journal-title":"J Exp Med"},{"issue":"5770","key":"2839_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/286264a0","volume":"286","author":"AW Ford-Hutchinson","year":"1980","unstructured":"Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980, 286 (5770): 264-265. 10.1038\/286264a0.","journal-title":"Nature"},{"issue":"4","key":"2839_CR39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1084\/jem.20052349","volume":"203","author":"ND Kim","year":"2006","unstructured":"Kim ND, Chou RC, Seung E, Tager AM, Luster AD: A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J Exp Med. 2006, 203 (4): 829-835. 10.1084\/jem.20052349.","journal-title":"J Exp Med"},{"issue":"11","key":"2839_CR40","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.4049\/jimmunol.163.11.6148","volume":"163","author":"A Matsukawa","year":"1999","unstructured":"Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL: Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol. 1999, 163 (11): 6148-6154.","journal-title":"J Immunol"},{"issue":"7","key":"2839_CR41","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.4049\/jimmunol.157.7.3105","volume":"157","author":"MJ Hebert","year":"1996","unstructured":"Hebert MJ, Takano T, Holthofer H, Brady HR: Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. J Immunol. 1996, 157 (7): 3105-3115.","journal-title":"J Immunol"},{"issue":"6","key":"2839_CR42","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1164\/ajrccm.161.6.9907054","volume":"161","author":"E Lee","year":"2000","unstructured":"Lee E, Robertson T, Smith J, Kilfeather S: Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med. 2000, 161 (6): 1881-1886.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"2839_CR43","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1073\/pnas.77.7.4354","volume":"77","author":"JM Drazen","year":"1980","unstructured":"Drazen JM, Austen KF, Lewis RA, Clark DA, Goto G, Marfat A, Corey EJ: Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A. 1980, 77 (7): 4354-4358. 10.1073\/pnas.77.7.4354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2839_CR44","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1073\/pnas.78.6.3887","volume":"78","author":"SE Dahlen","year":"1981","unstructured":"Dahlen SE, Bj\u00f6rk J, Hedqvist P, Arfors KE, Hammarstr\u00f6m S, Lindgren J\u00c5, Samuelsson B: Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A. 1981, 78 (6): 3887-3891. 10.1073\/pnas.78.6.3887.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2839_CR45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4049\/jimmunol.175.2.713","volume":"175","author":"I Prinz","year":"2005","unstructured":"Prinz I, Gregoire C, Mollenkopf H, Aguado E, Wang Y, Malissen M, Kaufmann SH, Malissen B: The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta- and gamma delta effector T cells. J Immunol. 2005, 175 (2): 713-719.","journal-title":"J Immunol"},{"issue":"10","key":"2839_CR46","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.4049\/jimmunol.173.10.6393","volume":"173","author":"K Okunishi","year":"2004","unstructured":"Okunishi K, Dohi M, Nakagome K, Tanaka R, Yamamoto K: A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol. 2004, 173 (10): 6393-6402.","journal-title":"J Immunol"},{"issue":"2","key":"2839_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2567.2011.03478.x","volume":"134","author":"C Alvarez","year":"2011","unstructured":"Alvarez C, Amaral MM, Langellotti C, Vermeulen M: Leukotriene C(4) prevents the complete maturation of murine dendritic cells and modifies interleukin-12\/interleukin-23 balance. Immunology. 2011, 134 (2): 185-197. 10.1111\/j.1365-2567.2011.03478.x.","journal-title":"Immunology"},{"issue":"5","key":"2839_CR48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1084\/jem.20020044","volume":"195","author":"EA Mellor","year":"2002","unstructured":"Mellor EA, Austen KF, Boyce JA: Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med. 2002, 195 (5): 583-592. 10.1084\/jem.20020044.","journal-title":"J Exp Med"},{"issue":"4","key":"2839_CR49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/01.HYP.7.4.507","volume":"7","author":"Z Zukowska-Grojec","year":"1985","unstructured":"Zukowska-Grojec Z, Bayorh MA, Kopin IJ, Feuerstein G: Overall and regional hemodynamic effects of leukotriene D4in spontaneously hypertensive rats. Hypertension. 1985, 7 (4): 507-513. 10.1161\/01.HYP.7.4.507.","journal-title":"Hypertension"},{"issue":"1","key":"2839_CR50","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/sj.bjp.0705405","volume":"140","author":"F Stanke-Labesque","year":"2003","unstructured":"Stanke-Labesque F, Hardy G, Caron F, Cracowski JL, Bessard G: Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated rats. Br J Pharmacol. 2003, 140 (1): 186-194. 10.1038\/sj.bjp.0705405.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2839_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0149-7634(05)80182-4","volume":"16","author":"FC Barone","year":"1992","unstructured":"Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ: Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev. 1992, 16 (2): 219-233. 10.1016\/S0149-7634(05)80182-4.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"2839_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0165-0270(02)00322-9","volume":"122","author":"T Gerriets","year":"2003","unstructured":"Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, Fisher M: The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods. 2003, 122 (2): 201-211. 10.1016\/S0165-0270(02)00322-9.","journal-title":"J Neurosci Methods"},{"issue":"2","key":"2839_CR53","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jneumeth.2010.08.026","volume":"193","author":"M Boyko","year":"2010","unstructured":"Boyko M, Zlotnik A, Gruenbaum BF, Gruenbaum SE, Ohayon S, Goldsmith T, Kotz R, Leibowitz A, Sheiner E, Shapira Y, et al: An experimental model of focal ischemia using an internal carotid artery approach. J Neurosci Methods. 2010, 193 (2): 246-253. 10.1016\/j.jneumeth.2010.08.026.","journal-title":"J Neurosci Methods"},{"issue":"10","key":"2839_CR54","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/01.STR.29.10.2162","volume":"29","author":"R Schmid-Elsaesser","year":"1998","unstructured":"Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ: A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke. 1998, 29 (10): 2162-2170. 10.1161\/01.STR.29.10.2162.","journal-title":"Stroke"},{"issue":"1","key":"2839_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989, 20 (1): 84-91. 10.1161\/01.STR.20.1.84.","journal-title":"Stroke"},{"key":"2839_CR56","volume-title":"Modeling stroke in mice - middle cerebral artery occlusion with the filament model","author":"O Engel","year":"2011","unstructured":"Engel O, Kolodziej S, Dirnagl U, Prinz V: Modeling stroke in mice - middle cerebral artery occlusion with the filament model. J Vis Exp. 2011, 10.3791\/2423. pii: 2423, 47"},{"issue":"16","key":"2839_CR57","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1097\/00001756-199811160-00012","volume":"9","author":"CV Borlongan","year":"1998","unstructured":"Borlongan CV, Hida H, Nishino H: Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery. Neuroreport. 1998, 9 (16): 3615-3621. 10.1097\/00001756-199811160-00012.","journal-title":"Neuroreport"},{"issue":"9","key":"2839_CR58","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1161\/01.STR.27.9.1657","volume":"27","author":"EJ Goldlust","year":"1996","unstructured":"Goldlust EJ, Paczynski RP, He YY, Hsu CY, Goldberg MP: Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains. Stroke. 1996, 27 (9): 1657-1662. 10.1161\/01.STR.27.9.1657.","journal-title":"Stroke"},{"issue":"4","key":"2839_CR59","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/jcbfm.2010.220","volume":"31","author":"C Kilkenny","year":"2011","unstructured":"Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG: Animal research: reporting in vivo experiments\u2013the ARRIVE guidelines. J Cereb Blood Flow Metab. 2011, 31 (4): 991-993. 10.1038\/jcbfm.2010.220.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2839_CR60","doi-asserted-by":"crossref","unstructured":"Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999, 30 (12): 2752-2758.","DOI":"10.1161\/01.STR.30.12.2752"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-13-146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T07:33:18Z","timestamp":1687851198000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-13-146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,30]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2839"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-13-146","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,30]]},"assertion":[{"value":"17 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"146"}}